Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Smart goals in finance clarify priorities, provide metrics, and create accountability, making it easier to track progress and adjust as needed.
22,836 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Kontoor Brands posted Q4 2025 results with revenue above $1B and a solid earnings beat, driven by a key acquisition. ...
Costco has built a durable earnings engine on membership loyalty and disciplined spending. This guide breaks down wha...
Two March data drops could tease the next cost-of-living adjustment for social security retirees, even though the off...
Bitcoin slides below 70,000 as ICP and PI buck the broader market, delivering notable gains while Ethereum fights to ...
Tech shares rebound as AI demand supports earnings. This report highlights the best tech stocks right now, detailing ...
Peloton pivots to the commercial gym market with a new Commercial Series, sending shares higher as it targets gym cha...
Solana's on-chain DApp revenue falls to $22 million, the lowest in 18 months, while SOL hovers around the $80 level a...
As defense budgets stabilize and technology explodes, investors are re-pricing defense names. This piece examines why...
KelpDAO publicly disputes LayerZero's account of the April breach and unveils plans to migrate to Chainlink CCIP, sig...
Berkshire Hathaway names Greg Abel as CEO, with Buffett signaling strong confidence as the company holds a cash-heavy...
Analysts say social security’s COLA could climb in 2027 as inflation holds steady and energy costs remain volatile du...